Posted by Michael Wonder on 21 Feb 2023
The FDA returns to its bad habits
20 February 2023 - The agency may nix a new treatment for a debilitating orphan disease.
Drug treatments for debilitating diseases are advancing rapidly, but the FDA isn’t moving with as much alacrity. Witness how the agency has slow rolled its review of a breakthrough treatment for a rare degenerative nervous system disorder.
